Since posting my rant on the now age old debate about paternalism (or as the people over in USA are calling it: Nanny State) versus public health, I have been reading a lot more about the Soda wars and it emerges that now it is way more hotly debated than ever before. Following in the … Continue reading Anti-Bloomberg Bill in the Soda Wars: Two Wrongs do not Make a Right!
Month: April 2013
The Family Physician: A Dying Romantic Idea
I have been known to lament the loss of the prestige of the basic medical degree (MBBS) in India. While you may or may not agree with it, the truth remains that nobody who is doing (or has recently done) an MBBS course wants to stay out at that level. Everyone wants to go and … Continue reading The Family Physician: A Dying Romantic Idea
USMLE 2013 and IMGs: All That Glitters is NOT Gold
I have pretty much been declared the official (Indian) USMLE rumor-monger by one of the most famous USMLE coaching institutes that held introductory classes to tell the masses what USMLE was all about. Thank you sir, you made my day. Now, again, another disclaimer. The last time I wrote about the USMLE match (this one: … Continue reading USMLE 2013 and IMGs: All That Glitters is NOT Gold
New York Soda Rule: Raising the Debate on Paternalism in Public Health
Paternalistic attitude in unilateral implementation of public health policies, especially with respect to banning of (harmful) substances, has been one of the issues that I have been debating not only with my colleagues, but also with my own self, for a while now. Aside from the obvious stake in the matter as a student of … Continue reading New York Soda Rule: Raising the Debate on Paternalism in Public Health
Another Start-up Bites the Dust: Elsevier Buys Mendeley
When TechCrunch reported that there were talks going on between Elsevier and Mendeley this January, I did not want to believe it. Being an ardent user and advocate of the platform, I wanted it to stay out of the clutches of Big Pub. But it is now official, Mendeley has been acqui-hired by Elsevier for … Continue reading Another Start-up Bites the Dust: Elsevier Buys Mendeley
Scepticemia 